Group 1 - The company is proposing a 2025 restricted stock incentive plan to attract and retain talent, aligning the interests of shareholders, the company, and core team members [4][7][8] - The plan includes granting 1,063,608 restricted shares, representing approximately 0.7077% of the company's total share capital of 150,292,062 shares [4][5] - The company aims to ensure the smooth implementation of the incentive plan through a management assessment method [7][8] Group 2 - The company will hold a shareholders' meeting on August 4, 2025, at 14:00 in Beijing, with both on-site and online voting options available [3][5] - Shareholders must register and present necessary identification documents to participate in the meeting [2][3] - The meeting will include discussions on the proposed incentive plan and the authorization for the board to manage related matters [6][8] Group 3 - The company is seeking authorization from shareholders for the board to handle various aspects of the incentive plan, including determining grant dates and adjusting share quantities in case of capital changes [8][9] - The board will also be authorized to manage and adjust the incentive plan as necessary, ensuring compliance with legal and regulatory requirements [9][10] - The company plans to renew its audit firm, Tianjian Accounting Firm, for the 2025 fiscal year, emphasizing the need for continuity in audit services [9][10]

证券代码：301297 证券简称：富乐德 上市地点：深圳证券交易所 安徽富乐德科技发展股份有限公司 关于 发行股份、可转换公司债券购买资产并募集配套资金 暨关联交易 之 可转换公司债券发行结果暨登记完成的公告 独立财务顾问 二〇二五年七月 上市公司声明 本公司及全体董事、监事、高级管理人员保证本公告书内容的真实、准 确、完整，并对本公告书的虚假记载、误导性陈述或重大遗漏负个别及连带责 任。 本公司全体董事、监事、高级管理人员承诺："如因提供的信息和文件存在 虚假记载、误导性陈述或者重大遗漏，给上市公司或者投资者造成损失的，将 依法承担个别和连带的法律责任。" 本次交易完成后，本公司经营与收益的变化，由本公司自行负责；因本次 交易引致的投资风险，由投资者自行负责。投资者若对本公告书存在任何疑 问，应咨询自己的股票经纪人、律师、专业会计师或其他专业顾问。 本公司提醒投资者注意：本公告书的目的仅为向公众提供有关本次交易的 实施情况，投资者如欲了解更多信息，请仔细阅读《安徽富乐德科技发展股份 有限公司发行股份、可转换公司债券购买资产并募集配套资金暨关联交易报告 书（草案）（注册稿）》全文及其他相关文件，该等文件已刊载 ...

Core Viewpoint - The company intends to appoint Tianjian Accounting Firm as the auditor for the fiscal year 2025, replacing the previous auditor, Tianzhi International Accounting Firm, to ensure the independence and objectivity of the audit process [1][6]. Group 1: Auditor Appointment Details - The proposed accounting firm is Tianjian Accounting Firm, established on July 18, 2011, with a registered address in Hangzhou, Zhejiang Province [1]. - Tianjian has 241 partners and 2,356 registered accountants, with 904 of them having signed securities service audit reports [1]. - The audit service fee for the fiscal year 2025 is set at 550,000 yuan (including tax) for financial audit and 150,000 yuan (including tax) for internal control audit, remaining unchanged from the previous year [5][7]. Group 2: Reasons for Change - The change in auditors is due to Tianzhi International having provided audit services for several consecutive years, and to maintain the independence and objectivity of the audit work as per relevant regulations [1][6]. - The company has communicated with both the outgoing and incoming auditors, and there are no objections from Tianzhi International regarding this change [6][7]. Group 3: Previous Auditor's Performance - Tianzhi International has provided audit services for the company for nine consecutive years and issued a standard unqualified audit report for the fiscal year 2024 [6]. - The company did not terminate the previous auditor after commissioning part of the audit work [6]. Group 4: Audit Committee and Board Approval - The audit committee approved the appointment of Tianjian based on its audit quality, industry knowledge, independence, and market reputation [7]. - The board of directors unanimously approved the proposal with 9 votes in favor, 0 against, and 0 abstentions [7].

Core Viewpoint - The company has decided to reappoint Tianjian Accounting Firm as its auditing institution for the fiscal year 2025, following a thorough review by the board and the audit committee [1][7]. Group 1: Appointment of Auditor - The company held its 30th meeting of the second board and the 23rd meeting of the second supervisory board on July 16, 2025, where the proposal to reappoint Tianjian Accounting Firm was approved [1]. - Tianjian Accounting Firm was established on July 18, 2011, and operates as a special general partnership with a registered address in Hangzhou, Zhejiang Province [1]. - The firm has a total of 241 partners and 2,356 certified public accountants, with 904 of them having signed audit reports for securities services [1]. Group 2: Financial Performance of the Auditor - Tianjian Accounting Firm reported a total business income of 2.969 billion yuan, with audit business income of 2.563 billion yuan and securities business income of 1.465 billion yuan [1]. - The total audit fees collected by the firm amounted to 735 million yuan [1]. Group 3: Audit Committee Review - The audit committee reviewed Tianjian's professional competence, investor protection capabilities, integrity, and independence, concluding that the firm has performed its duties diligently and can continue to serve as the company's auditor for 2025 [6][7]. - The proposal for reappointment will be submitted to the shareholders' meeting for approval, and it will take effect upon approval [7].

Group 1 - China International Capital Corporation (CICC) acts as the sponsor for HANSAN (Nanjing) Technology Co., Ltd.'s initial public offering (IPO) on the ChiNext board, committing to compensate investors for losses due to false statements or omissions in the documents it produces [1] - Beijing Junhe Law Firm serves as the special legal advisor for the issuer's IPO, promising to compensate investors for losses caused by false statements or omissions in the documents it issues, while accepting supervision from regulatory bodies and the public [2] - The auditing firm for HANSAN (Nanjing) Technology Co., Ltd. commits to compensate investors for losses resulting from false statements or omissions in the audit reports and related documents it produces for the IPO [3] Group 2 - The verification and review institution for HANSAN (Nanjing) Technology Co., Ltd. also commits to compensate investors for losses due to false statements or omissions in the verification reports and related documents it issues for the IPO [6] - Kun Yuan Asset Appraisal Co., Ltd. acts as the appraisal agency for the issuer's IPO, promising to compensate investors for losses resulting from false statements or omissions in the asset appraisal report it produces, contingent upon a judicial ruling [8]

Core Viewpoint - The article discusses the disciplinary actions taken by the Shenzhen Stock Exchange against Tianjian Accounting Firm and its certified public accountants for their involvement in the financial fraud case of Sichuang Medical Technology Co., Ltd, highlighting the serious implications of falsified financial statements and inadequate auditing practices [1][4]. Group 1: Disciplinary Actions - Tianjian Accounting Firm and its certified public accountants Hu Yanlong, Xu Lili, and Ni Bin received disciplinary actions for their roles in the financial fraud case involving Sichuang Medical [1][4]. - Hu Yanlong and Xu Lili are prohibited from signing any issuance and disclosure documents from June 28, 2025, to June 27, 2026 [1][4]. - Tianjian Accounting Firm received a public reprimand, while Hu Yanlong and Xu Lili also faced public reprimands, and Ni Bin received a notice of criticism [1][4]. Group 2: Fraudulent Activities - Sichuang Medical was found to have fabricated significant false content in its public offering documents, including financial data from 2017 to 2020 [1][7]. - The company inflated revenue and profits through fictitious transactions with subsidiaries and early revenue recognition practices [1][7]. - The 2019 and 2020 annual reports of Sichuang Medical contained false records, failing to accurately disclose financial data [1][7]. Group 3: Audit Failures - Tianjian Accounting Firm failed to effectively identify and assess fraud risks during the audit of Sichuang Medical [1][8]. - The firm did not implement adequate audit procedures regarding abnormal revenue recognition and did not obtain sufficient appropriate audit evidence [1][9][10]. - There were discrepancies between the audit documentation and actual execution, indicating a lack of due diligence in the auditing process [1][12][13].

Group 1 - The company held its 24th meeting of the fifth supervisory board, with all supervisors present and all resolutions passed without opposition [1] - The supervisory board agreed to abolish the supervisory board and transfer its powers to the audit committee of the board of directors, along with the corresponding amendments to the company's governance documents [2][3] - The company will change its financial audit and internal control audit institutions for 2025, appointing Huaxing Accounting Firm as the new auditor [4] Group 2 - The company approved a warehouse and distribution contract with its associate company, Guangdong Shangnong Zhiyun Technology Co., Ltd., for logistics services, with pricing to be determined later [4]

Core Viewpoint - The company intends to change its auditing firm from Tianjian Accounting Firm to Huaxing Accounting Firm for the 2025 fiscal year to ensure the independence and objectivity of the audit process [2][5][6] Group 1: Change of Auditing Firm - The new auditing firm to be appointed is Huaxing Accounting Firm, while the previous firm was Tianjian Accounting Firm [2] - The change is motivated by the need for independent auditing, as Tianjian has provided services for several consecutive years [2][5] - The board of directors approved the proposal to change the auditing firm, which will be submitted to the shareholders' meeting for final approval [6] Group 2: Auditing Firm Information - Huaxing Accounting Firm was established on December 9, 2013, and operates as a special general partnership [3] - The firm has 71 partners and 346 certified public accountants, with 182 of them having signed securities service audit reports [3] - The total revenue of Huaxing Accounting Firm was 37,037.29 million yuan, with securities business revenue of 19,714.90 million yuan [3] Group 3: Audit Fees - The audit fees for 2025 are set at 600,000 yuan, with 450,000 yuan for financial report auditing and 150,000 yuan for internal control auditing, unchanged from 2024 [4] - The selection of the auditing firm was conducted through a bidding process, considering market prices [4] Group 4: Communication with Previous Auditing Firm - The company communicated with Tianjian Accounting Firm regarding the change, and there were no objections from the previous firm [5][6] - The transition follows the guidelines set forth in the Chinese CPA auditing standards regarding communication between the previous and new auditors [5] Group 5: Board and Committee Approval - The audit committee of the board reviewed Huaxing's qualifications and found them suitable for the company's auditing needs [6] - The board of directors unanimously approved the proposal to appoint Huaxing Accounting Firm [6]

Core Points - The company held its 29th meeting of the 10th Board of Directors on July 7, 2025, where several key resolutions were passed, including the appointment of a new accounting firm and changes in board composition [1][2][3][4][5][6][7][8][9][10][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71] Group 1 - The company plans to change its accounting firm from Tianjian CPA to Lixin CPA for the 2025 financial report and internal control audit due to the expiration of the service term of the former firm [1][45][46] - The board approved the addition of a new director, Ms. Yu Xingyue, nominated by the controlling shareholder, with her term starting from the approval date by the shareholders' meeting [3][4][57][58] - The company intends to simplify its structure by canceling the indirect holding subsidiary, Hainan Taiji Pharmaceutical Import and Export Co., Ltd., to focus on its core business [5][62][63][64] Group 2 - The company will acquire 100% of the shares of Yuncheng Taiji Smart Traditional Chinese Medicine Co., Ltd. by purchasing the 90% and 10% stakes held by its subsidiaries for a nominal price of 1 yuan [6][31][32] - The company’s subsidiary, Taiji Group Chongqing Fuling Pharmaceutical Factory, will acquire 40% of Hainan Taiji Marine Pharmaceutical Co., Ltd. for 248,000 yuan, increasing its ownership from 60% to 100% [7][31][32] - The company has decided to cancel the supervisory board, transferring its responsibilities to the audit committee of the board, and will revise its articles of association accordingly [8][69][70]

Group 1 - The company held its 29th meeting of the 10th Board of Directors on July 7, 2025, with 11 out of 12 directors present, and the meeting was deemed legal and effective [1][2] - The company proposed to change its accounting firm from Tianjian Accounting Firm to Lixin Accounting Firm due to the expiration of the service term, which requires shareholder approval [1][2] - The company plans to supplement its board of directors by nominating Ms. Yu Xingyue, with her term starting from the approval date by the shareholders [2][6] Group 2 - The company intends to simplify its structure by liquidating its indirect subsidiary, Hainan Taiji Pharmaceutical Import and Export Co., Ltd., to focus on its core business [2][3] - The company will acquire 100% equity of Yuncheng Taiji Smart Traditional Chinese Medicine Co., Ltd. by purchasing shares from its subsidiaries for a nominal price of 1 yuan [3][4] - The company’s subsidiary, Chongqing Fuling Pharmaceutical Factory, will acquire 40% equity of Hainan Taiji Marine Pharmaceutical Co., Ltd. for 2.48 million yuan, increasing its ownership from 60% to 100% [4][5] Group 3 - The company approved the cancellation of the supervisory board and the revision of its articles of association, pending shareholder approval [5][6] - The company revised several governance documents, including the rules for shareholder meetings and board meetings, which will also be submitted for shareholder approval [5][6] - The company announced the convening of its second extraordinary general meeting of shareholders in 2025 [5][6]